TR200002860T2 - Bir antiviral benzimidazol terkibin yeni kristal formları. - Google Patents

Bir antiviral benzimidazol terkibin yeni kristal formları.

Info

Publication number
TR200002860T2
TR200002860T2 TR2000/02860T TR200002860T TR200002860T2 TR 200002860 T2 TR200002860 T2 TR 200002860T2 TR 2000/02860 T TR2000/02860 T TR 2000/02860T TR 200002860 T TR200002860 T TR 200002860T TR 200002860 T2 TR200002860 T2 TR 200002860T2
Authority
TR
Turkey
Prior art keywords
crystal forms
new crystal
benzimidazole composition
antiviral
antiviral benzimidazole
Prior art date
Application number
TR2000/02860T
Other languages
English (en)
Inventor
Howard Carter Barry
Neal Glover Bobby
Huang Lian-Feng
William Lancaster Robert
Todd Long Stacey
Catherine Rizzolio Michele
Allen Schmitt Eric
Riddle Sickles Barry
Original Assignee
Glaxo Group Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Limited filed Critical Glaxo Group Limited
Publication of TR200002860T2 publication Critical patent/TR200002860T2/tr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/052—Imidazole radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/7056—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing five-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)

Abstract

Bu bulus 5,6-dikloro-2-(izopropilamino)-1-B-L-ribofuranosil-1H- benzimidazol'un fiziksel formlarina, farmasötik bilesimlere ve tibbi terapide kullanimlarina iliskindir.
TR2000/02860T 1998-04-07 1999-04-01 Bir antiviral benzimidazol terkibin yeni kristal formları. TR200002860T2 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9807354.7A GB9807354D0 (en) 1998-04-07 1998-04-07 Antiviral compound

Publications (1)

Publication Number Publication Date
TR200002860T2 true TR200002860T2 (tr) 2000-12-21

Family

ID=10829932

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2000/02860T TR200002860T2 (tr) 1998-04-07 1999-04-01 Bir antiviral benzimidazol terkibin yeni kristal formları.

Country Status (28)

Country Link
US (9) US6469160B1 (tr)
EP (1) EP1071693B1 (tr)
JP (1) JP2002510703A (tr)
KR (1) KR20010074472A (tr)
CN (1) CN1303390A (tr)
AP (1) AP2000001947A0 (tr)
AT (1) ATE261452T1 (tr)
AU (1) AU752877B2 (tr)
BR (1) BR9909474A (tr)
CA (1) CA2327494C (tr)
DE (1) DE69915461T2 (tr)
EA (1) EA002970B1 (tr)
EE (1) EE04120B1 (tr)
ES (1) ES2216503T3 (tr)
GB (1) GB9807354D0 (tr)
HR (1) HRP20000669A2 (tr)
HU (1) HUP0101669A3 (tr)
ID (1) ID27109A (tr)
IL (1) IL138697A0 (tr)
IS (1) IS5640A (tr)
NO (1) NO20005005L (tr)
NZ (1) NZ507173A (tr)
PL (1) PL343397A1 (tr)
SK (1) SK14832000A3 (tr)
TR (1) TR200002860T2 (tr)
WO (1) WO1999051618A1 (tr)
YU (1) YU60900A (tr)
ZA (1) ZA200005153B (tr)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9807354D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB0008939D0 (en) * 2000-04-11 2000-05-31 Glaxo Group Ltd Process for preparing substituted benzimidazole compounds
LT2767539T (lt) 2002-05-16 2017-09-25 Janssen Sciences Ireland Uc Pseudopolimorfinės živ proteazės inhibitorių formos
ES2370829T3 (es) * 2004-06-02 2011-12-23 Sandoz Ag Producto intermedio de meropenem en forma cristalina.
WO2007004230A2 (en) * 2005-07-05 2007-01-11 Hetero Drugs Limited A novel process for the preparation of didanosine using novel intermediates
US9198862B2 (en) * 2005-07-22 2015-12-01 Rubicon Research Private Limited Dispersible tablet composition
AU2006298881A1 (en) * 2005-09-21 2007-04-12 4Sc Ag Sulphonylpyrrole hydrochloride salts as histone deacetylases inhibitors
WO2007053427A2 (en) * 2005-10-31 2007-05-10 Janssen Pharmaceutica N.V. Novel processes for the preparation of piperazinyl and diazapanyl benzamide derivatives
EA016054B1 (ru) * 2006-06-16 2012-01-30 Х. Лундбекк А/С Кристаллические формы 4-[2-(4-метилфенилсульфанил)фенил] пиперидина с объединенным ингибированием повторного поглощения серотонина и норадреналина для лечения невропатической боли
US7919598B2 (en) * 2006-06-28 2011-04-05 Bristol-Myers Squibb Company Crystal structures of SGLT2 inhibitors and processes for preparing same
ES2442257T3 (es) * 2006-10-27 2014-02-10 Signal Pharmaceuticals Llc Formas sólidas que comprenden 4-[9-(tetrahidro-furan-3-il)-8-(2,4,6-trifluoro-fenilamino)-9H-purin-2-ilamino]-ciclohexan-1-ol, sus composiciones y sus usos
EP2085397A1 (en) * 2008-01-21 2009-08-05 Esteve Quimica, S.A. Crystalline form of abacavir
US7935817B2 (en) * 2008-03-31 2011-05-03 Apotex Pharmachem Inc. Salt form and cocrystals of adefovir dipivoxil and processes for preparation thereof
AR071318A1 (es) * 2008-04-15 2010-06-09 Basilea Pharmaceutica Ag Benzhidril ester del acido (6r,7r)-7-{2-(5-amino-[1,2,4]tiadiazol-3-il)-2-[(z)-tritiloxiimino]-acetilamino}-3-[(r)-1'-terc-butoxicarbonil-2-oxo-[1,3']bipirrolidinil-(3e)-ilidenometil]-8-oxo-5-tia-1-aza-biciclo[4.2.0]oct-2-eno-2-carboxilico cristalino; su elaboracion y uso
US8097719B2 (en) * 2008-07-15 2012-01-17 Genesen Labs Meropenem intermediate in novel crystalline form and a method of manufacture of meropenem
KR101043794B1 (ko) * 2009-04-13 2011-06-27 청우산업 주식회사 황토판재로 제공되는 기능성 황토방
KR101512548B1 (ko) 2010-03-12 2015-04-15 오메로스 코포레이션 Pde10 억제제 및 관련 조성물 및 방법
WO2012030957A2 (en) * 2010-09-01 2012-03-08 Arena Pharmaceuticals, Inc. Non-hygroscopic salts of 5-ht2c agonists
US8546344B2 (en) * 2010-10-28 2013-10-01 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl)-1H-benzimidazole
US8541391B2 (en) 2010-10-28 2013-09-24 Viropharma Incorporated Crystalline phases of 5,6-dichloro-2-(isopropylamino)-1-β-L-ribofuranosyl-1H-benzimidazole
US8940707B2 (en) 2010-10-28 2015-01-27 Viropharma Incorporated Maribavir isomers, compositions, methods of making and methods of using
WO2013044816A1 (en) * 2011-09-30 2013-04-04 Sunshine Lake Pharma Co., Ltd. Crystalline forms of azilsartan and preparation and uses thereof
NZ630810A (en) 2014-04-28 2016-03-31 Omeros Corp Processes and intermediates for the preparation of a pde10 inhibitor
NZ716462A (en) 2014-04-28 2017-11-24 Omeros Corp Optically active pde10 inhibitor
JP2018513153A (ja) 2015-04-24 2018-05-24 オメロス コーポレーション Ｐｄｅ１０インヒビターならびに関連する組成物および方法
WO2017079678A1 (en) 2015-11-04 2017-05-11 Omeros Corporation Solid state forms of a pde10 inhibitor
CN111303230B (zh) * 2020-03-09 2021-07-13 中国食品药品检定研究院 一种黄体酮共晶物及其制备方法和用途
WO2024081308A1 (en) * 2022-10-12 2024-04-18 Takeda Pharmaceutical Company Limited Method of preparing maribavir

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3399987A (en) * 1965-08-02 1968-09-03 United States Borax Chem 2-alkylaminobenzimidazoles as herbicides
CH443777A (de) * 1965-08-06 1968-02-15 Agripat Sa Verfahren zum Schützen textiler Keratinfasern vor Insektenfrass und Mittel zur Durchführung dieses Verfahrens
US3655901A (en) * 1970-07-30 1972-04-11 Merck & Co Inc Method of inhibiting the formation of phenylethanalamine-n-methyl transferase with 2-aminobenzimidazoles
SE9003151D0 (sv) * 1990-10-02 1990-10-02 Medivir Ab Nucleoside derivatives
US5248672A (en) * 1990-11-01 1993-09-28 The Regents Of The University Of Michigan Polysubstituted benzimidazole nucleosides as antiviral agents
WO1994008456A1 (en) * 1992-10-21 1994-04-28 The Regents Of The University Of Michigan Polysubstituted benzimidazoles as antiviral agents
GB9413724D0 (en) 1994-07-07 1994-08-24 Wellcome Found Therapeutic nucleosides
GB9600143D0 (en) 1996-01-05 1996-03-06 Wellcome Found Therapeutic compounds
GB9807354D0 (en) * 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound
GB9807355D0 (en) 1998-04-07 1998-06-03 Glaxo Group Ltd Antiviral compound

Also Published As

Publication number Publication date
ATE261452T1 (de) 2004-03-15
US20110118203A1 (en) 2011-05-19
YU60900A (sh) 2003-07-07
ZA200005153B (en) 2001-09-26
HRP20000669A2 (en) 2001-08-31
JP2002510703A (ja) 2002-04-09
US9163052B2 (en) 2015-10-20
US20180044366A1 (en) 2018-02-15
ID27109A (id) 2001-03-01
EE200000584A (et) 2002-04-15
EE04120B1 (et) 2003-08-15
US7297683B2 (en) 2007-11-20
DE69915461T2 (de) 2005-03-03
EA002970B1 (ru) 2002-12-26
HUP0101669A3 (en) 2003-07-28
US20130261294A1 (en) 2013-10-03
US20160030460A1 (en) 2016-02-04
NZ507173A (en) 2003-07-25
AU3603499A (en) 1999-10-25
WO1999051618A1 (en) 1999-10-14
CA2327494C (en) 2010-10-26
IL138697A0 (en) 2001-10-31
DE69915461D1 (de) 2004-04-15
EP1071693B1 (en) 2004-03-10
US20020177703A1 (en) 2002-11-28
US7714123B2 (en) 2010-05-11
EP1071693A1 (en) 2001-01-31
PL343397A1 (en) 2001-08-13
EA200000911A1 (ru) 2001-04-23
AU752877B2 (en) 2002-10-03
US20100179101A1 (en) 2010-07-15
US20080103186A1 (en) 2008-05-01
IS5640A (is) 2000-09-26
GB9807354D0 (en) 1998-06-03
NO20005005D0 (no) 2000-10-04
AP2000001947A0 (en) 2000-12-31
US6469160B1 (en) 2002-10-22
CN1303390A (zh) 2001-07-11
NO20005005L (no) 2000-12-06
ES2216503T3 (es) 2004-10-16
CA2327494A1 (en) 1999-10-14
BR9909474A (pt) 2000-12-19
US20170002035A1 (en) 2017-01-05
HUP0101669A2 (hu) 2001-10-28
SK14832000A3 (sk) 2001-07-10
KR20010074472A (ko) 2001-08-04

Similar Documents

Publication Publication Date Title
TR200002860T2 (tr) Bir antiviral benzimidazol terkibin yeni kristal formları.
EE03523B1 (et) Fenantridiinid, neid sisaldavad ravimid ja nende kasutamine
TR199901172T2 (tr) Yeni ikame edilmis pirazol türevleri.
TR200103233T2 (tr) Antikolinerjik etkili bileşik ve ß-mimetikler bazında yeni ilaç bileşimleri.
ES2189235T3 (es) 6-fenilfenantridinas sustituidas.
CY1108610T1 (el) Πεπτιδια της il-2 και παραγωγα αυτων και χρηση αυτων ως θεραπευτικοι παραγοντες
TR199901305T2 (tr) Calpain-önleyicileri olarak ketonbenzamidler
TR200102800T2 (tr) Yeni bileşikler.
TR200000009T2 (tr) Triazol bileşikleri ve bunların dopamin-D3-ligandları olarak kullanımları.
TR199901905T2 (tr) 2-(Pürin-9-il)-tetrahidrofuran-3,4-diol türevleri.
TR200002218T2 (tr) 2-(Pürin-9-il)-Tetrahidrofüran -3,4-Diol türevleri
TR199901417T2 (tr) Analjezik etkisi olan yeni bilesimler.
EE04054B1 (et) Tetrasoolderivaadid, nende kasutamine ravimite valmistamiseks ja neid sisaldav ravim
ATE330959T1 (de) Allosterische adenosin-rezeptor-modulatore
TR199802284T2 (tr) Dopamin D3 reseptörlerinin modülatörleri olarak tetrahidroizokuinolin türevleri.
DK1053256T3 (da) Antistoffer mod Dødsreceptor 4 (DR4) og anvendelser deraf
DK0889886T5 (da) Hidtil ukendte, i 6-stilling substituerede phenanthridiner
TR199902334T2 (tr) Psikotik bozukluklarin tedavisi veya profilaksisi için mirtazapin ve antipsikotik ajanlarin yeni terapötik kombinasyonlari.
AR020563A1 (es) Compuestos (poli)tia-alquinoicos y sus derivados, composiciones que los incluyen y su utilizacion
TR200101979T2 (tr) Antidepresyon tedavisi için 5HT1 antagonistleri.
TR199902094T2 (tr) 3-Heteroareil-4(3H)-kinazolinonlarin atropizomerleri.
ATE199641T1 (de) Terpenderivate (sarcodictyine) als antikrebsmittel
EA200000909A1 (ru) ФОРМА VI 5,6-ДИХЛОР-2-(ИЗОПРОПИЛАМИНО)-1-(b-L-РИБОФУРАНОЗИЛ)-1H-БЕНЗИМИДАЗОЛА
TR200100801T2 (tr) Benzoilguanidin türevleri, imalatlarına yönelik yöntemler, ilaç yapımında kullanımı
TR199901385T2 (tr) Piperidin türevleri.